tradingkey.logo

Bone Biologics Corp

BBLGW
상세 차트 보기
12.550USD
-6.240-33.21%
종가 02/06, 16:00ET시세는 15분 지연됩니다
0.00시가총액
--P/E TTM

Bone Biologics Corp

12.550
-6.240-33.21%
Intraday
1m
30m
1h
D
W
M
D

오늘

-33.21%

5일

-20.32%

1개월

+3.29%

6개월

0.00%

올해 현재까지

-61.38%

1년

-86.13%

상세 차트 보기

TradingKey 주식 점수

데이터가 부족하여 주식 점수를 확인할 수 없습니다.

Bone Biologics Corp 뉴스

더 많은 뉴스가 곧 업데이트됩니다. 계속 지켜봐 주세요…

재무 지표

EPS

기업이 아직 관련 데이터를 공개하지 않았습니다.

총 수익

기업이 아직 관련 데이터를 공개하지 않았습니다.

Bone Biologics Corp 정보

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
종목 코드 BBLGW
회사Bone Biologics Corp
CEOMr. Jeffrey Frelick
웹사이트https://www.bonebiologics.com/
KeyAI